CD3 epsilon/CD3e Protein, Cynomolgus, Recombinant (aa 22-117, hFc)

Artikelnummer: TGM-TMPJ-01259
Artikelname: CD3 epsilon/CD3e Protein, Cynomolgus, Recombinant (aa 22-117, hFc)
Artikelnummer: TGM-TMPJ-01259
Hersteller Artikelnummer: TMPJ-01259
Alternativnummer: TGM-TMPJ-01259-1MG,TGM-TMPJ-01259-5UG,TGM-TMPJ-01259-10UG,TGM-TMPJ-01259-20UG,TGM-TMPJ-01259-50UG,TGM-TMPJ-01259-100UG,TGM-TMPJ-01259-200UG,TGM-TMPJ-01259-500UG
Hersteller: TargetMol
Kategorie: Biochemikalien
Alternative Synonym: CD3 epsilon , T-cell antigen receptor complex, epsilon subunit of T3 , CD3e antigen, epsilon polypeptide (TiT3 complex) , T-cell surface antigen T3/Leu-4 epsilon chain , CD3e antigen, epsilon polypeptide (TiT3 complex) , T-cell antigen receptor complex, epsilon subunit of T3 , CD3e antigen , FLJ18683 , CD3e , CD3e molecule, epsilon (CD3-TCR complex) , CD3 epsilon , CD3e molecule, epsilon (CD3-TCR complex) , T3E , CD3-epsilon , T-cell surface antigen T3/Leu-4 epsilon chain , CD3-epsilon
T-cell surface glycoprotein CD3 epsilon chain, also known as CD3E, is a single-pass type I membrane protein. CD3E contains 1 Ig-like (immunoglobulin-like) domain and 1 ITAM domain. CD3E, together with CD3-gamma, CD3-delta and CD3-zeta, and the T-cell receptor alpha/beta and gamma/delta heterodimers, forms the T cell receptor-CD3 complex. The CD3 epsilon subunit of the T cell receptor (TCR) complex contains two defined signaling domains, a proline-rich sequence and an immune tyrosine activation motifs (ITAMs), and this complex undergoes a conformational change upon ligand binding that is thought to be important for the activation of T cells. T cell receptor-CD3 complex plays an important role in coupling antigen recognition to several intracellular signal-transduction pathways. This complex is critical for T-cell development and function, and represents one of the most complex transmembrane receptors. CD3E plays an essential role in T-cell development, and defects in CD3E gene cause severe immunodeficiency. Homozygous mutations in CD3D and CD3E genes lead to a complete block in T-cell development and thus to an early-onset severe combined immunodeficiency phenotype.
TMPJ-01259